Sun Pharma shares down 3%; m-cap dips by Rs 5,004 cr

Image
Press Trust of India New Delhi
Last Updated : Apr 07 2017 | 7:32 PM IST
Shares of Sun Pharma fell by 3 per cent today amid reports of USFDA inspection at one of the company's plant.
The stock slipped 3.04 per cent to end at Rs 665.65 on BSE. During the day, it dipped 3.48 per cent to Rs 662.60.
The scrip was the worst performer among the 30-Sensex stocks.
On NSE, it fell by 3 per cent to close at Rs 665.95.
The company's market capitalisation or m-cap tumbled Rs 5,004.17 crore to Rs 1,59,704.83 crore.
On the volume front, 7.47 lakh shares of the company were traded on BSE and over 60 lakh shares changed hands on NSE during the day.
As per reports, the USFDA conducted inspections at the company's Dadra plant.
The Sensex stayed in the negative zone for the whole day and settled lower by 220.73 points, or 0.74 per cent, at 29,706.61.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 07 2017 | 7:32 PM IST

Next Story